 | • レポートコード：D005-00747 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、次世代がん診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。次世代がん診断の種類別市場規模（次世代シーケンシング、qPCR＆マルチプレックス、DNAマイクロアレイ、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Cepheid、Opko Health、Qiagen、Koninklijke Philips N.V、Thermo Fisher Scientific、F. Hoffmann-La Roche Ltd、Agilent Technologies、Abbott、Novartis AG、Myriad Genetics、Hologic、Sysmex Corporation、GE Healthcare、Almac Group、Illumina、PerkinElmer、Janssen Global Services、Genomic Health ・地域別グローバル市場分析 2015年-2020年 ・次世代がん診断の北米市場（アメリカ、カナダ、メキシコ） ・次世代がん診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・次世代がん診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・次世代がん診断の南米市場（ブラジル、アルゼンチン） ・次世代がん診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：次世代シーケンシング、qPCR＆マルチプレックス、DNAマイクロアレイ、その他 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Next Generation Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 17.7% in the forecast period of 2020 to 2025 and will expected to reach USD 10560 million by 2025, from USD 5506.2 million in 2019.
The Next Generation Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Next Generation Cancer Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Next Generation Cancer Diagnostics market has been segmented into:
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Other
By Application, Next Generation Cancer Diagnostics has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Next Generation Cancer Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Next Generation Cancer Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Next Generation Cancer Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the Next Generation Cancer Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Next Generation Cancer Diagnostics Market Share Analysis
Next Generation Cancer Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Next Generation Cancer Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Next Generation Cancer Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in Next Generation Cancer Diagnostics are:
Cepheid
Opko Health
Qiagen
Koninklijke Philips N.V
Thermo Fisher Scientific
F. Hoffmann-La Roche Ltd
Agilent Technologies
Abbott
Novartis AG
Myriad Genetics
Hologic
Sysmex Corporation
GE Healthcare
Almac Group
Illumina
PerkinElmer
Janssen Global Services
Genomic Health
Table of Contents
1 Next Generation Cancer Diagnostics Market Overview
1.1 Product Overview and Scope of Next Generation Cancer Diagnostics
1.2 Classification of Next Generation Cancer Diagnostics by Type
1.2.1 Global Next Generation Cancer Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Type in 2019
1.2.3 Next Generation Sequencing
1.2.4 qPCR & Multiplexing
1.2.5 DNA Microarrays
1.2.6 Other
1.3 Global Next Generation Cancer Diagnostics Market by Application
1.3.1 Overview: Global Next Generation Cancer Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Next Generation Cancer Diagnostics Market by Regions
1.4.1 Global Next Generation Cancer Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Next Generation Cancer Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Next Generation Cancer Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Next Generation Cancer Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Next Generation Cancer Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Next Generation Cancer Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Next Generation Cancer Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Cepheid
2.1.1 Cepheid Details
2.1.2 Cepheid Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Cepheid SWOT Analysis
2.1.4 Cepheid Product and Services
2.1.5 Cepheid Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Opko Health
2.2.1 Opko Health Details
2.2.2 Opko Health Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Opko Health SWOT Analysis
2.2.4 Opko Health Product and Services
2.2.5 Opko Health Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Qiagen
2.3.1 Qiagen Details
2.3.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Qiagen SWOT Analysis
2.3.4 Qiagen Product and Services
2.3.5 Qiagen Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Koninklijke Philips N.V
2.4.1 Koninklijke Philips N.V Details
2.4.2 Koninklijke Philips N.V Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Koninklijke Philips N.V SWOT Analysis
2.4.4 Koninklijke Philips N.V Product and Services
2.4.5 Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Thermo Fisher Scientific SWOT Analysis
2.5.4 Thermo Fisher Scientific Product and Services
2.5.5 Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 F. Hoffmann-La Roche Ltd
2.6.1 F. Hoffmann-La Roche Ltd Details
2.6.2 F. Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 F. Hoffmann-La Roche Ltd SWOT Analysis
2.6.4 F. Hoffmann-La Roche Ltd Product and Services
2.6.5 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Agilent Technologies
2.7.1 Agilent Technologies Details
2.7.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Agilent Technologies SWOT Analysis
2.7.4 Agilent Technologies Product and Services
2.7.5 Agilent Technologies Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Abbott
2.8.1 Abbott Details
2.8.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Abbott SWOT Analysis
2.8.4 Abbott Product and Services
2.8.5 Abbott Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis AG SWOT Analysis
2.9.4 Novartis AG Product and Services
2.9.5 Novartis AG Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Myriad Genetics
2.10.1 Myriad Genetics Details
2.10.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Myriad Genetics SWOT Analysis
2.10.4 Myriad Genetics Product and Services
2.10.5 Myriad Genetics Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Hologic
2.11.1 Hologic Details
2.11.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Hologic SWOT Analysis
2.11.4 Hologic Product and Services
2.11.5 Hologic Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sysmex Corporation
2.12.1 Sysmex Corporation Details
2.12.2 Sysmex Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sysmex Corporation SWOT Analysis
2.12.4 Sysmex Corporation Product and Services
2.12.5 Sysmex Corporation Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.13 GE Healthcare
2.13.1 GE Healthcare Details
2.13.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 GE Healthcare SWOT Analysis
2.13.4 GE Healthcare Product and Services
2.13.5 GE Healthcare Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Almac Group
2.14.1 Almac Group Details
2.14.2 Almac Group Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Almac Group SWOT Analysis
2.14.4 Almac Group Product and Services
2.14.5 Almac Group Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Illumina
2.15.1 Illumina Details
2.15.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Illumina SWOT Analysis
2.15.4 Illumina Product and Services
2.15.5 Illumina Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.16 PerkinElmer
2.16.1 PerkinElmer Details
2.16.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 PerkinElmer SWOT Analysis
2.16.4 PerkinElmer Product and Services
2.16.5 PerkinElmer Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.17 Janssen Global Services
2.17.1 Janssen Global Services Details
2.17.2 Janssen Global Services Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Janssen Global Services SWOT Analysis
2.17.4 Janssen Global Services Product and Services
2.17.5 Janssen Global Services Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.18 Genomic Health
2.18.1 Genomic Health Details
2.18.2 Genomic Health Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Genomic Health SWOT Analysis
2.18.4 Genomic Health Product and Services
2.18.3 Genomic Health Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Next Generation Cancer Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Next Generation Cancer Diagnostics Players Market Share
3.2.2 Top 10 Next Generation Cancer Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Next Generation Cancer Diagnostics Revenue and Market Share by Regions
4.2 North America Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Next Generation Cancer Diagnostics Revenue by Countries
5.1 North America Next Generation Cancer Diagnostics Revenue by Countries (2015-2020)
5.2 USA Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Next Generation Cancer Diagnostics Revenue by Countries
6.1 Europe Next Generation Cancer Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Next Generation Cancer Diagnostics Revenue by Countries
7.1 Asia-Pacific Next Generation Cancer Diagnostics Revenue by Countries (2015-2020)
7.2 China Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Next Generation Cancer Diagnostics Revenue by Countries
8.1 South America Next Generation Cancer Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Next Generation Cancer Diagnostics by Countries
9.1 Middle East & Africa Next Generation Cancer Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Next Generation Cancer Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Next Generation Cancer Diagnostics Market Forecast by Type (2019-2024)
10.3 Next Generation Sequencing Revenue Growth Rate (2015-2025)
10.4 qPCR & Multiplexing Revenue Growth Rate (2015-2025)
10.5 DNA Microarrays Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Next Generation Cancer Diagnostics Market Segment by Application
11.1 Global Next Generation Cancer Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Next Generation Cancer Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Next Generation Cancer Diagnostics Market Size Forecast (2021-2025)
12.1 Global Next Generation Cancer Diagnostics Market Size Forecast (2021-2025)
12.2 Global Next Generation Cancer Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Next Generation Cancer Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Next Generation Cancer Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Next Generation Cancer Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Next Generation Cancer Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Next Generation Cancer Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Next Generation Cancer Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Next Generation Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Next Generation Cancer Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Next Generation Cancer Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Cepheid Corporate Information, Location and Competitors
Table 6. Cepheid Next Generation Cancer Diagnostics Major Business
Table 7. Cepheid Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Cepheid SWOT Analysis
Table 9. Cepheid Next Generation Cancer Diagnostics Product and Solutions
Table 10. Cepheid Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Opko Health Corporate Information, Location and Competitors
Table 12. Opko Health Next Generation Cancer Diagnostics Major Business
Table 13. Opko Health Next Generation Cancer Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. Opko Health SWOT Analysis
Table 15. Opko Health Next Generation Cancer Diagnostics Product and Solutions
Table 16. Opko Health Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Qiagen Corporate Information, Location and Competitors
Table 18. Qiagen Next Generation Cancer Diagnostics Major Business
Table 19. Qiagen Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. Qiagen SWOT Analysis
Table 21. Qiagen Next Generation Cancer Diagnostics Product and Solutions
Table 22. Qiagen Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Koninklijke Philips N.V Corporate Information, Location and Competitors
Table 24. Koninklijke Philips N.V Next Generation Cancer Diagnostics Major Business
Table 25. Koninklijke Philips N.V Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Koninklijke Philips N.V SWOT Analysis
Table 27. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product and Solutions
Table 28. Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 30. Thermo Fisher Scientific Next Generation Cancer Diagnostics Major Business
Table 31. Thermo Fisher Scientific Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Thermo Fisher Scientific SWOT Analysis
Table 33. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product and Solutions
Table 34. Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. F. Hoffmann-La Roche Ltd Corporate Information, Location and Competitors
Table 36. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Major Business
Table 37. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 39. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product and Solutions
Table 40. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Agilent Technologies Corporate Information, Location and Competitors
Table 42. Agilent Technologies Next Generation Cancer Diagnostics Major Business
Table 43. Agilent Technologies Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. Agilent Technologies SWOT Analysis
Table 45. Agilent Technologies Next Generation Cancer Diagnostics Product and Solutions
Table 46. Agilent Technologies Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Abbott Corporate Information, Location and Competitors
Table 48. Abbott Next Generation Cancer Diagnostics Major Business
Table 49. Abbott Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. Abbott SWOT Analysis
Table 51. Abbott Next Generation Cancer Diagnostics Product and Solutions
Table 52. Abbott Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Novartis AG Corporate Information, Location and Competitors
Table 54. Novartis AG Next Generation Cancer Diagnostics Major Business
Table 55. Novartis AG Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 56. Novartis AG SWOT Analysis
Table 57. Novartis AG Next Generation Cancer Diagnostics Product and Solutions
Table 58. Novartis AG Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Myriad Genetics Corporate Information, Location and Competitors
Table 60. Myriad Genetics Next Generation Cancer Diagnostics Major Business
Table 61. Myriad Genetics Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 62. Myriad Genetics SWOT Analysis
Table 63. Myriad Genetics Next Generation Cancer Diagnostics Product and Solutions
Table 64. Myriad Genetics Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Hologic Corporate Information, Location and Competitors
Table 66. Hologic Next Generation Cancer Diagnostics Major Business
Table 67. Hologic Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 68. Hologic SWOT Analysis
Table 69. Hologic Next Generation Cancer Diagnostics Product and Solutions
Table 70. Hologic Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Sysmex Corporation Corporate Information, Location and Competitors
Table 72. Sysmex Corporation Next Generation Cancer Diagnostics Major Business
Table 73. Sysmex Corporation Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 74. Sysmex Corporation SWOT Analysis
Table 75. Sysmex Corporation Next Generation Cancer Diagnostics Product and Solutions
Table 76. Sysmex Corporation Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. GE Healthcare Corporate Information, Location and Competitors
Table 78. GE Healthcare Next Generation Cancer Diagnostics Major Business
Table 79. GE Healthcare Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 80. GE Healthcare SWOT Analysis
Table 81. GE Healthcare Next Generation Cancer Diagnostics Product and Solutions
Table 82. GE Healthcare Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Almac Group Corporate Information, Location and Competitors
Table 84. Almac Group Next Generation Cancer Diagnostics Major Business
Table 85. Almac Group Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 86. Almac Group SWOT Analysis
Table 87. Almac Group Next Generation Cancer Diagnostics Product and Solutions
Table 88. Almac Group Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Illumina Corporate Information, Location and Competitors
Table 90. Illumina Next Generation Cancer Diagnostics Major Business
Table 91. Illumina Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 92. Illumina SWOT Analysis
Table 93. Illumina Next Generation Cancer Diagnostics Product and Solutions
Table 94. Illumina Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. PerkinElmer Corporate Information, Location and Competitors
Table 96. PerkinElmer Next Generation Cancer Diagnostics Major Business
Table 97. PerkinElmer Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 98. PerkinElmer SWOT Analysis
Table 99. PerkinElmer Next Generation Cancer Diagnostics Product and Solutions
Table 100. PerkinElmer Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Janssen Global Services Corporate Information, Location and Competitors
Table 102. Janssen Global Services Next Generation Cancer Diagnostics Major Business
Table 103. Janssen Global Services Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 104. Janssen Global Services SWOT Analysis
Table 105. Janssen Global Services Next Generation Cancer Diagnostics Product and Solutions
Table 106. Janssen Global Services Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Genomic Health Next Generation Cancer Diagnostics Type and Application
Table 108. Genomic Health Next Generation Cancer Diagnostics Major Business
Table 109. Genomic Health Next Generation Cancer Diagnostics Total Revenue (USD Million) (2017-2018)
Table 110. Genomic Health SWOT Analysis
Table 111. Genomic Health Next Generation Cancer Diagnostics Product and Solutions
Table 112. Genomic Health Next Generation Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Global Next Generation Cancer Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 114. Global Next Generation Cancer Diagnostics Revenue Share by Players (2015-2020)
Table 115. Global Next Generation Cancer Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 116. Global Next Generation Cancer Diagnostics Revenue Market Share by Regions (2015-2020)
Table 117. North America Next Generation Cancer Diagnostics Revenue by Countries (2015-2020)
Table 118. North America Next Generation Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 119. Europe Next Generation Cancer Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 120. Asia-Pacific Next Generation Cancer Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 121. South America Next Generation Cancer Diagnostics Revenue by Countries (2015-2020)
Table 122. South America Next Generation Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 123. Middle East and Africa Next Generation Cancer Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 124. Middle East and Africa Next Generation Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Table 125. Global Next Generation Cancer Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 126. Global Next Generation Cancer Diagnostics Revenue Share by Type (2015-2020)
Table 127. Global Next Generation Cancer Diagnostics Revenue Forecast by Type (2021-2025)
Table 128. Global Next Generation Cancer Diagnostics Revenue by Application (2015-2020)
Table 129. Global Next Generation Cancer Diagnostics Revenue Share by Application (2015-2020)
Table 130. Global Next Generation Cancer Diagnostics Revenue Forecast by Application (2021-2025)
Table 131. Global Next Generation Cancer Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Next Generation Cancer Diagnostics Picture
Figure 2. Global Next Generation Cancer Diagnostics Revenue Market Share by Type in 2019
Figure 3. Next Generation Sequencing Picture
Figure 4. qPCR & Multiplexing Picture
Figure 5. DNA Microarrays Picture
Figure 6. Other Picture
Figure 7. Next Generation Cancer Diagnostics Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Other Picture
Figure 11. Global Next Generation Cancer Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Next Generation Cancer Diagnostics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Next Generation Cancer Diagnostics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Next Generation Cancer Diagnostics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Next Generation Cancer Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Next Generation Cancer Diagnostics Revenue Market Share by Regions in 2018
Figure 25. North America Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. South America Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. North America Next Generation Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Next Generation Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 32. USA Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Next Generation Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Next Generation Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 37. Germany Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. UK Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. France Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Next Generation Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Next Generation Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 44. China Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. India Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. South America Next Generation Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Next Generation Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 51. Brazil Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Next Generation Cancer Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Next Generation Cancer Diagnostics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Next Generation Cancer Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. Global Next Generation Cancer Diagnostics Revenue Share by Type (2015-2020)
Figure 60. Global Next Generation Cancer Diagnostics Revenue Share by Type in 2019
Figure 61. Global Next Generation Cancer Diagnostics Market Share Forecast by Type (2021-2025)
Figure 62. Global Next Generation Sequencing Revenue Growth Rate (2015-2020)
Figure 63. Global qPCR & Multiplexing Revenue Growth Rate (2015-2020)
Figure 64. Global DNA Microarrays Revenue Growth Rate (2015-2020)
Figure 65. Global Other Revenue Growth Rate (2015-2020)
Figure 66. Global Next Generation Cancer Diagnostics Revenue Share by Application (2015-2020)
Figure 67. Global Next Generation Cancer Diagnostics Revenue Share by Application in 2019
Figure 68. Global Next Generation Cancer Diagnostics Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Next Generation Cancer Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Next Generation Cancer Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Next Generation Cancer Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Next Generation Cancer Diagnostics Revenue Market Forecast (2021-2025)
Figure 76. Europe Next Generation Cancer Diagnostics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Next Generation Cancer Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. South America Next Generation Cancer Diagnostics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Next Generation Cancer Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
次世代がん診断装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Next Generation Cancer Diagnostic Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nex…- 非侵襲的がん診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Noninvasive Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 127940 million by 2025, from USD 110450 million in 2019. The Nonin…
- 皮膚がん診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Skin Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Skin Cancer Diagnosti…
- 膀胱がん治療・診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bladder Cancer Therapeutics and Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 551.5 million by 2025, from USD 427.6 million in 2019…
- 前立腺がん診断の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Prostate Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.0% in the forecast period of 2020 to 2025 and will expected to reach USD 15640 million by 2025, from USD 11940 million in 2019. The Pr…